Genmab A's Customers Performance

Name: Genmab A Customers by Division and Industry - CSIMarket
Creator: CSIMarket.com
License: https://csimarket.com/help/terms-of-use

GMAB

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.


GMAB's Source of Revenues		During the corresponding time, Genmab A While revenue at the Genmab A's corporate clients • List of GMAB Customers

for the same period Genmab A

• List of GMAB Customers

Genmab A's Business Units


DARZALEX	65.67 %	of total Revenue
Kesimpta	11.91 %	of total Revenue
TEPEZZA	2.82 %	of total Revenue
Other	0.59 %	of total Revenue
Janssen	68.95 %	of total Revenue
AbbVie	1.77 %	of total Revenue
Roche	2.85 %	of total Revenue
Novartis	11.99 %	of total Revenue
BioNTech	1.08 %	of total Revenue
Pfizer	2.07 %	of total Revenue
Royalties	83.39 %	of total Revenue
Net product Sales	10.7 %	of total Revenue
Reimbursement revenue	1.42 %	of total Revenue
Milestone revenue	2.61 %	of total Revenue
Collaboration revenue	1.88 %	of total Revenue
Excluding net product Sales	89.3 %	of total Revenue
Denmark	89.41 %	of total Revenue
Netherlands	0.03 %	of total Revenue
United States	4.84 %	of total Revenue
Japan	5.73 %	of total Revenue

Select the Relationship:

Customers ▼

Select the Category:

Comparison ▼

Customers ▼

Basic Report▼

Genmab A's Comment on Sales, Marketing and Customers

The company's customers are subject to federal and state healthcare laws and regulations, including the federal Anti-Kickback Statute, federal civil and criminal false claims laws, and the Health Insurance Portability and Accountability Act (HIPAA). These laws govern business and financial arrangements related to healthcare services and programs such as Medicare and Medicaid, with the intent to prevent fraud, abuse, and improper remuneration in healthcare transactions. Customers operate in markets associated with federal healthcare programs and are required to comply with privacy, security, and transmission standards for individually identifiable health information.

Genmab A’s Comment on Sales, Marketing and Customers

GMAB's Stock Performance relative to it's Customers

GMAB's vs. Customers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)

COMPANY NAME	MARKET CAP	REVENUES	INCOME	EMPLOYEES
Genmab A	2,262.95	3,720.00	963.00	3,029
SUBTOTAL	0.00	0.00	0.00	-

Sources: Genmab A’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: Genmab A’s corporate clients.
For your research, we’ve provided 9 tables on Genmab A corporate clients.
You can find them in the navigation menu under Customers & Markets.
To download the tables, please subscribe.

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.